Abstract: The present invention relates to a cosmetic comprising a neutral polysaccharide obtained from an acid-fast bacterium. This cosmetic smoothly spreads on the skin without sticking to the skin to give moistness to the skin. Furthermore, the cosmetic covers the skin and shows an excellent moisture-retaining action, and exerts an effect of preventing or moderating the rough skin.
Abstract: A lipopolysaccharide characterized by a polysaccharide portion composed of D-arabinose and D-mannose in a 1:3/4 ration and 37 to 47% of a fatty acid portion having 14-19 carbon atoms bonded to the polysaccharide through an ester linkage. This lipopolysaccharide has physiological activities such as antitumor activity, immunizing activity, cell juvenescent activity, phagocyte activating activity, and infection preventing activity.This lipopolysaccharide is prepared by culturing a Mycobacterium or a Propionibacterium and extracting the lipopolysaccharide from the culture with a non-ionic surface active agent and purifying the extract with a molecular sieve.
Abstract: Cycloartenol ferulate/cyclodextrin complex is prepared by including cycloartenol ferulate, which is a component of .gamma.-oryzanol and hardly soluble in water, with cyclodextrin to thereby elevate its solubility in water and improve its absorption through digestive tracts. Thus various pharmaceutical and physiological effects of cycloartenol ferulate are further improved.
Abstract: A process for sugar-coating a solid preparation such as tablet, pill, granule or grain with a sugar-coating liquid comprising pullulan and/or a water-soluble derivative thereof dissolved in an aqueous solution of sucrose. The solid preparation sugar-coated by the above-mentioned process exhibits an enhanced impact strength and shelf life.
Abstract: An anti-inflammatory agent comprising as an active component an inhibitor specifically inhibiting a thiol protease, which is obtained from human urine by extraction and purification. This agent has an action of inhibiting a disease caused by a thiol protease. This anti-inflammatory agent is prepared by a process in which a thiol protease inhibitor is extracted and purified from human urine by adopting in combination at least two treatments selected from a treatment with a molecular filter, a treatment with an ion exchanger, a treatment with an adsorber and an affinity chromatographic treatment.
Abstract: Disclosed is a urokinase preparation for oral administration which is effective for remedy of thrombosis such as cerebral thrombosis and cardiac infarction. This preparation comprises urokinase and, incorporated therein, glycoprotein.
Abstract: Disclosed is a urokinase preparation for oral administration which is effective for remedy of thrombosis such as cerebral thrombosis and cardiac infarction. This preparation comprises urokinase and, incorporated therein, an enzyme inhibitor.